Adjuvant selection for optimally balanced humoral and cellular immunity induced by SARS-CoV-2 Spike virosome vaccines
Marloes Grobben, Gius Kerster, Esther Siteur-van Rijnstra, Mitch Brinkkemper, Meliawati Poniman, Judith A. Burger, Khadija Tejjani, Jacqueline van Rijswijk, Widad Ait Iddouch, Melissa Oomen, Joey H. Bouhuijs, Tom P. L. Bijl, Ronald Kempers, Kwinten Sliepen, Toon Stegmann, , Rogier W. Sanders
The paper evaluates adjuvant effects on immune responses in virosome-based SARS-CoV-2 vaccines, finding distinct impacts on humoral and cellular immunity.
bioRxiv · Jun 24, 2026 · PreprintImmunology